Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for ORIC

Stock Name	Oric Pharmaceuticals Inc
Ticker	ORIC(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US68622P1093
LEI	54930033FJRNEYBW0L25

Show aggregate ORIC holdings

News associated with ORIC

Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Moderate Buy” from Analysts: Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 12-month price target […] - 2025-09-19 03:15:02
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $17.63: Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average 12-month […] - 2025-08-28 03:12:47
JPMorgan Chase & Co. Has Lowered Expectations for Oric Pharmaceuticals (NASDAQ:ORIC) Stock Price: Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) had its price target decreased by JPMorgan Chase & Co. from $20.00 to $17.00 in a research report sent to investors on Thursday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. ORIC has been the subject of a number of other reports. Oppenheimer lowered […] - 2025-08-15 04:52:49
Victory Capital Management Inc. Has $838,000 Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC): Victory Capital Management Inc. raised its holdings in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 150,260 shares of the company’s stock after buying an additional 52,760 shares during the period. Victory Capital Management Inc.’s […] - 2025-08-01 05:01:17
Arizona State Retirement System Purchases New Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC): Arizona State Retirement System purchased a new stake in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the first quarter, Holdings Channel reports. The institutional investor purchased 10,088 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds have also modified their holdings of ORIC. Vanguard Group Inc. increased its […] - 2025-07-24 04:38:53
LADENBURG THALM/SH SH Initiates Coverage on Oric Pharmaceuticals (NASDAQ:ORIC): LADENBURG THALM/SH SH assumed coverage on shares of Oric Pharmaceuticals (NASDAQ:ORIC – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $15.00 price target on the stock. Several other equities research analysts have also recently weighed in on ORIC. Oppenheimer decreased their price objective on Oric […] - 2025-07-11 02:36:47
Brokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $19.17: Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have received an average rating of “Buy” from the nine brokerages that are covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have issued a report on the stock […] - 2025-07-09 02:33:02
Oric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up After Insider Buying Activity: Oric Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Tuesday following insider buying activity. The stock had previously closed at $10.00, but opened at $10.63. Oric Pharmaceuticals shares last traded at $10.87, with a volume of 484,723 shares. Specifically, Director Angie You acquired 26,597 shares of the firm’s stock […] - 2025-06-25 02:22:47
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 54.5% during the fourth quarter, Holdings Channel reports. The fund owned 35,579 shares of the company’s stock after purchasing an additional 12,545 shares during the quarter. UBS AM a […] - 2025-06-13 04:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of “Buy” by Analysts: Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are currently covering the company, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have covered the stock […] - 2025-06-11 03:08:48
Thursday's ETF Movers: XBI, URA: In trading on Thursday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 1.9% on the day. Components of that ETF showing particular strength include shares of Oric Pharmaceuticals, up about 33.8% and shares of Replimune Group, up about 9.6% on the day. And un - 2025-05-29 12:59:01
Janus Henderson Group PLC Makes New Investment in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): Janus Henderson Group PLC acquired a new stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 14,600 shares of the company’s stock, valued at approximately $118,000. Several other institutional investors have also recently modified their holdings of the company. KLP Kapitalforvaltning AS purchased a […] - 2025-05-26 04:51:01
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Target Price at $19.17: Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) have been assigned an average rating of “Buy” from the eight brokerages that are covering the firm, Marketbeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokers that have updated their coverage on […] - 2025-05-22 05:30:55
Tower Research Capital LLC TRC Purchases 13,384 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): Tower Research Capital LLC TRC lifted its position in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 1,048.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,661 shares of the company’s stock after purchasing an additional 13,384 shares during the quarter. […] - 2025-05-09 05:21:00
MetLife Investment Management LLC Purchases 5,530 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): MetLife Investment Management LLC grew its position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 41,608 shares of the company’s stock after acquiring an additional 5,530 shares during the period. MetLife Investment […] - 2025-05-07 05:28:51
HC Wainwright Reiterates Buy Rating for ORIC Pharmaceuticals (NASDAQ:ORIC): ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a note issued to investors on Monday,Benzinga reports. They currently have a $21.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 316.67% from the stock’s previous close. Other analysts […] - 2025-05-07 02:58:49
XTX Topco Ltd Has $210,000 Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC): XTX Topco Ltd increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 120.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,966 shares of the company’s stock after acquiring an additional 14,209 shares during the period. XTX […] - 2025-04-28 05:11:12
Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) PT at $18.86: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received a consensus recommendation of “Buy” from the nine brokerages that are currently covering the company, Marketbeat reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have covered the stock in the last year […] - 2025-04-25 02:32:47
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Wellington Management Group LLP: Wellington Management Group LLP increased its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) by 6.9% during the fourth quarter, HoldingsChannel reports. The fund owned 186,430 shares of the company’s stock after buying an additional 12,042 shares during the period. Wellington Management Group LLP’s holdings in ORIC Pharmaceuticals were worth $1,504,000 at […] - 2025-04-14 04:45:06
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.86 Consensus PT from Brokerages: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has been assigned an average rating of “Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have covered the stock in […] - 2025-03-31 02:32:43
ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Better-Than-Expected Earnings: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) shares gapped up prior to trading on Wednesday following a better than expected earnings announcement. The stock had previously closed at $7.85, but opened at $8.57. ORIC Pharmaceuticals shares last traded at $7.99, with a volume of 78,926 shares traded. The company reported ($0.51) EPS for the […] - 2025-02-21 04:56:45
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Buy” from Analysts: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Get Free Report) has received an average recommendation of “Buy” from the nine research firms that are presently covering the stock, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued a report on the stock in […] - 2025-02-11 06:30:52

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) ORIC holdings

Date	Number of ORIC Shares Held	Base Market Value of ORIC Shares	Local Market Value of ORIC Shares	Change in ORIC Shares Held	Change in ORIC Base Value	Current Price per ORIC Share Held	Previous Price per ORIC Share Held
2026-01-15 (Thursday)	65,058	USD 749,468	USD 749,468	296	USD 20,895	USD 11.52	USD 11.25
2026-01-14 (Wednesday)	64,762	USD 728,573	USD 728,573	298	USD 74,908	USD 11.25	USD 10.14
2026-01-13 (Tuesday)	64,464	USD 653,665	USD 653,665	0	USD 63,819	USD 10.14	USD 9.15001
2026-01-12 (Monday)	64,464	USD 589,846	USD 589,846	298	USD 2,727	USD 9.15001	USD 9.15
2026-01-09 (Friday)	64,166	USD 587,119	USD 587,119	447	USD 48,693	USD 9.15	USD 8.45001
2026-01-08 (Thursday)	63,719	USD 538,426	USD 538,426	0	USD -14,655	USD 8.45001	USD 8.68
2026-01-07 (Wednesday)	63,719	USD 553,081	USD 553,081	298	USD 36,834	USD 8.68	USD 8.14
2026-01-06 (Tuesday)	63,421	USD 516,247	USD 516,247	0	USD -634	USD 8.14	USD 8.15
2026-01-05 (Monday)	63,421	USD 516,881	USD 516,881	0	USD -1,269	USD 8.15	USD 8.17001
2026-01-02 (Friday)	63,421	USD 518,150	USD 518,150	149	USD 585	USD 8.17001	USD 8.18
2025-12-31 (Wednesday)	63,272	USD 517,565	USD 517,565	0	USD 6,327	USD 8.18	USD 8.08

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ORIC by Blackrock for IE00BDZVHG35

Show aggregate share trades of ORIC

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2026-01-15 BUY 296 11.560 11.080 11.128 USD 3,294 9.06
2026-01-14 BUY 298 11.770 10.040 10.213 USD 3,043 9.05
2026-01-12 BUY 298 9.390 8.770 8.832 USD 2,632 9.05
2026-01-09 BUY 447 9.230 8.540 8.609 USD 3,848 9.05
2026-01-07 BUY 298 8.920 8.190 8.263 USD 2,462 9.05
2026-01-02 BUY 149 8.330 8.040 8.069 USD 1,202 9.06
2025-12-30 BUY 149 8.330 7.955 7.992 USD 1,191 9.07
2025-12-23 SELL -1,800 8.565 8.190 8.227 USD -14,809 9.09 Profit of 1,546 on sale
2025-12-19 SELL -5,484 8.240 7.980 8.006 USD -43,905 9.09 Profit of 5,970 on sale
2025-12-17 SELL -815 9.230 8.200 8.303 USD -6,767 9.10 Profit of 652 on sale
2025-12-16 SELL -163 9.415 8.820 8.879 USD -1,447 9.10 Profit of 36 on sale
2025-12-15 BUY 326 9.501 9.185 9.217 USD 3,005 9.10
2025-12-11 BUY 334 10.090 9.645 9.690 USD 3,236 9.10
2025-12-04 BUY 3,220 11.540 10.720 10.802 USD 34,782 9.06
2025-12-02 BUY 2,430 11.245 10.445 10.525 USD 25,576 9.04
2025-11-28 BUY 162 12.140 11.742 11.782 USD 1,909 9.02
2025-11-26 BUY 486 11.950 11.460 11.509 USD 5,593 8.99
2025-11-26 BUY 486 11.950 11.460 11.509 USD 5,593 8.99
2025-11-25 BUY 810 12.290 11.470 11.552 USD 9,357 8.98
2025-11-24 BUY 162 12.005 11.500 11.551 USD 1,871 8.96
2025-11-20 SELL -644 12.500 11.210 11.339 USD -7,302 8.94 Loss of -1,547 on sale
2025-11-19 BUY 161 12.040 11.470 11.527 USD 1,856 8.92
2025-11-18 BUY 966 12.145 11.510 11.574 USD 11,180 8.91
2025-11-17 BUY 322 12.710 11.280 11.423 USD 3,678 8.89
2025-11-14 BUY 161 13.450 12.135 12.266 USD 1,975 8.87
2025-11-12 BUY 161 12.965 12.390 12.448 USD 2,004 8.84
2025-11-10 BUY 160 12.860 12.330 12.383 USD 1,981 8.80
2025-11-06 BUY 160 12.910 12.160 12.235 USD 1,958 8.76
2025-11-04 BUY 161 12.710 12.160 12.215 USD 1,967 8.72
2025-10-30 BUY 805 13.510 12.752 12.828 USD 10,326 8.64
2025-10-29 BUY 322 12.930 13.570 13.506 USD 4,349 8.62
2025-10-22 SELL -640 12.080 12.562 12.514 USD -8,009 8.50 Loss of -2,571 on sale
2025-10-20 BUY 320 12.380 13.070 13.001 USD 4,160 8.45
2025-10-17 BUY 799 12.780 13.350 13.293 USD 10,621 8.42
2025-10-15 BUY 1,272 13.900 14.040 14.026 USD 17,841 8.39
2025-10-03 BUY 1,127 11.565 11.710 11.695 USD 13,181 8.34
2025-10-02 BUY 161 11.320 11.839 11.787 USD 1,898 8.33
2025-09-30 BUY 322 12.000 12.050 12.045 USD 3,878 8.28
2025-09-26 BUY 322 11.120 11.220 11.210 USD 3,610 8.25
2025-09-25 BUY 322 10.410 10.650 10.626 USD 3,422 8.23
2025-09-18 BUY 129 11.000 11.171 11.154 USD 1,439 8.21
2025-09-17 BUY 387 10.520 11.160 11.096 USD 4,294 8.20
2025-07-17 SELL -254 11.140 11.570 11.527 USD -2,928 8.13 Loss of -864 on sale
2025-07-16 BUY 2,554 11.180 11.380 11.360 USD 29,013 8.11
2025-07-11 SELL -960 11.100 11.420 11.388 USD -10,932 8.05 Loss of -3,204 on sale
2025-07-02 BUY 6,600 10.650 11.190 11.136 USD 73,498 7.97
2025-06-25 BUY 240 10.230 10.870 10.806 USD 2,593 7.91
2025-06-11 BUY 242 9.390 10.040 9.975 USD 2,414 7.78
2025-06-10 BUY 242 9.750 10.000 9.975 USD 2,414 7.77
2025-06-04 SELL -122 9.080 9.090 9.089 USD -1,109 7.72 Loss of -167 on sale
2025-04-23 BUY 123 5.170 5.660 5.611 USD 690 8.31
2025-04-10 SELL -984 4.310 4.605 4.576 USD -4,502 8.65 Profit of 4,014 on sale
2025-04-08 SELL -123 4.255 4.990 4.916 USD -605 8.75 Profit of 472 on sale
2025-04-07 SELL -122 4.590 5.010 4.968 USD -606 8.80 Profit of 467 on sale
2025-04-04 SELL -615 4.880 5.180 5.150 USD -3,167 8.85 Profit of 2,272 on sale
2025-04-01 BUY 492 5.530 5.680 5.665 USD 2,787 8.92
2025-03-31 SELL -369 5.580 5.890 5.859 USD -2,162 8.96 Profit of 1,145 on sale
2025-03-21 BUY 3,098 7.030 7.470 7.426 USD 23,006 9.15
2025-03-14 SELL -1,808 7.790 7.960 7.943 USD -14,361 9.26 Profit of 2,375 on sale
2025-03-07 SELL -226 8.000 8.040 8.036 USD -1,816 9.37 Profit of 301 on sale
2025-03-04 SELL -113 7.660 7.790 7.777 USD -879 9.44 Profit of 188 on sale
2025-02-25 BUY 226 8.080 8.120 8.116 USD 1,834 9.57
2025-02-19 SELL -112 7.940 8.570 8.507 USD -953 9.71 Profit of 134 on sale
2025-02-13 BUY 333 8.270 9.640 9.503 USD 3,164 9.83
2025-02-12 BUY 111 9.450 9.690 9.666 USD 1,073 9.83
2025-02-11 BUY 440 9.850 11.720 11.533 USD 5,075 9.83
2024-12-30 SELL -3,746 8.170 8.290 8.278 USD -31,009 9.42 Profit of 4,269 on sale
2024-11-18 SELL -1,803 8.560 8.805 8.781 USD -15,831 9.30 Profit of 940 on sale
2024-11-08 SELL -120 10.260 10.290 10.287 USD -1,234 9.17 Loss of -135 on sale
2024-10-21 SELL -122 9.120 9.450 9.417 USD -1,149 0.00 Loss of -1,149 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2026-01-15	BUY	296	11.560	11.080	11.128	USD 3,294	9.06
2026-01-14	BUY	298	11.770	10.040	10.213	USD 3,043	9.05
2026-01-12	BUY	298	9.390	8.770	8.832	USD 2,632	9.05
2026-01-09	BUY	447	9.230	8.540	8.609	USD 3,848	9.05
2026-01-07	BUY	298	8.920	8.190	8.263	USD 2,462	9.05
2026-01-02	BUY	149	8.330	8.040	8.069	USD 1,202	9.06
2025-12-30	BUY	149	8.330	7.955	7.992	USD 1,191	9.07
2025-12-23	SELL	-1,800	8.565	8.190	8.227	USD -14,809	9.09 Profit of 1,546 on sale
2025-12-19	SELL	-5,484	8.240	7.980	8.006	USD -43,905	9.09 Profit of 5,970 on sale
2025-12-17	SELL	-815	9.230	8.200	8.303	USD -6,767	9.10 Profit of 652 on sale
2025-12-16	SELL	-163	9.415	8.820	8.879	USD -1,447	9.10 Profit of 36 on sale
2025-12-15	BUY	326	9.501	9.185	9.217	USD 3,005	9.10
2025-12-11	BUY	334	10.090	9.645	9.690	USD 3,236	9.10
2025-12-04	BUY	3,220	11.540	10.720	10.802	USD 34,782	9.06
2025-12-02	BUY	2,430	11.245	10.445	10.525	USD 25,576	9.04
2025-11-28	BUY	162	12.140	11.742	11.782	USD 1,909	9.02
2025-11-26	BUY	486	11.950	11.460	11.509	USD 5,593	8.99
2025-11-26	BUY	486	11.950	11.460	11.509	USD 5,593	8.99
2025-11-25	BUY	810	12.290	11.470	11.552	USD 9,357	8.98
2025-11-24	BUY	162	12.005	11.500	11.551	USD 1,871	8.96
2025-11-20	SELL	-644	12.500	11.210	11.339	USD -7,302	8.94 Loss of -1,547 on sale
2025-11-19	BUY	161	12.040	11.470	11.527	USD 1,856	8.92
2025-11-18	BUY	966	12.145	11.510	11.574	USD 11,180	8.91
2025-11-17	BUY	322	12.710	11.280	11.423	USD 3,678	8.89
2025-11-14	BUY	161	13.450	12.135	12.266	USD 1,975	8.87
2025-11-12	BUY	161	12.965	12.390	12.448	USD 2,004	8.84
2025-11-10	BUY	160	12.860	12.330	12.383	USD 1,981	8.80
2025-11-06	BUY	160	12.910	12.160	12.235	USD 1,958	8.76
2025-11-04	BUY	161	12.710	12.160	12.215	USD 1,967	8.72
2025-10-30	BUY	805	13.510	12.752	12.828	USD 10,326	8.64
2025-10-29	BUY	322	12.930	13.570	13.506	USD 4,349	8.62
2025-10-22	SELL	-640	12.080	12.562	12.514	USD -8,009	8.50 Loss of -2,571 on sale
2025-10-20	BUY	320	12.380	13.070	13.001	USD 4,160	8.45
2025-10-17	BUY	799	12.780	13.350	13.293	USD 10,621	8.42
2025-10-15	BUY	1,272	13.900	14.040	14.026	USD 17,841	8.39
2025-10-03	BUY	1,127	11.565	11.710	11.695	USD 13,181	8.34
2025-10-02	BUY	161	11.320	11.839	11.787	USD 1,898	8.33
2025-09-30	BUY	322	12.000	12.050	12.045	USD 3,878	8.28
2025-09-26	BUY	322	11.120	11.220	11.210	USD 3,610	8.25
2025-09-25	BUY	322	10.410	10.650	10.626	USD 3,422	8.23
2025-09-18	BUY	129	11.000	11.171	11.154	USD 1,439	8.21
2025-09-17	BUY	387	10.520	11.160	11.096	USD 4,294	8.20
2025-07-17	SELL	-254	11.140	11.570	11.527	USD -2,928	8.13 Loss of -864 on sale
2025-07-16	BUY	2,554	11.180	11.380	11.360	USD 29,013	8.11
2025-07-11	SELL	-960	11.100	11.420	11.388	USD -10,932	8.05 Loss of -3,204 on sale
2025-07-02	BUY	6,600	10.650	11.190	11.136	USD 73,498	7.97
2025-06-25	BUY	240	10.230	10.870	10.806	USD 2,593	7.91
2025-06-11	BUY	242	9.390	10.040	9.975	USD 2,414	7.78
2025-06-10	BUY	242	9.750	10.000	9.975	USD 2,414	7.77
2025-06-04	SELL	-122	9.080	9.090	9.089	USD -1,109	7.72 Loss of -167 on sale
2025-04-23	BUY	123	5.170	5.660	5.611	USD 690	8.31
2025-04-10	SELL	-984	4.310	4.605	4.576	USD -4,502	8.65 Profit of 4,014 on sale
2025-04-08	SELL	-123	4.255	4.990	4.916	USD -605	8.75 Profit of 472 on sale
2025-04-07	SELL	-122	4.590	5.010	4.968	USD -606	8.80 Profit of 467 on sale
2025-04-04	SELL	-615	4.880	5.180	5.150	USD -3,167	8.85 Profit of 2,272 on sale
2025-04-01	BUY	492	5.530	5.680	5.665	USD 2,787	8.92
2025-03-31	SELL	-369	5.580	5.890	5.859	USD -2,162	8.96 Profit of 1,145 on sale
2025-03-21	BUY	3,098	7.030	7.470	7.426	USD 23,006	9.15
2025-03-14	SELL	-1,808	7.790	7.960	7.943	USD -14,361	9.26 Profit of 2,375 on sale
2025-03-07	SELL	-226	8.000	8.040	8.036	USD -1,816	9.37 Profit of 301 on sale
2025-03-04	SELL	-113	7.660	7.790	7.777	USD -879	9.44 Profit of 188 on sale
2025-02-25	BUY	226	8.080	8.120	8.116	USD 1,834	9.57
2025-02-19	SELL	-112	7.940	8.570	8.507	USD -953	9.71 Profit of 134 on sale
2025-02-13	BUY	333	8.270	9.640	9.503	USD 3,164	9.83
2025-02-12	BUY	111	9.450	9.690	9.666	USD 1,073	9.83
2025-02-11	BUY	440	9.850	11.720	11.533	USD 5,075	9.83
2024-12-30	SELL	-3,746	8.170	8.290	8.278	USD -31,009	9.42 Profit of 4,269 on sale
2024-11-18	SELL	-1,803	8.560	8.805	8.781	USD -15,831	9.30 Profit of 940 on sale
2024-11-08	SELL	-120	10.260	10.290	10.287	USD -1,234	9.17 Loss of -135 on sale
2024-10-21	SELL	-122	9.120	9.450	9.417	USD -1,149	0.00 Loss of -1,149 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ORIC

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	312,228	0	401,879	77.7%
2025-09-18	189,657	0	290,975	65.2%
2025-09-17	196,609	14,866	429,152	45.8%
2025-09-16	274,498	0	389,947	70.4%
2025-09-15	387,562	0	505,219	76.7%
2025-09-12	251,354	6,075	360,700	69.7%
2025-09-11	237,238	0	345,079	68.7%
2025-09-10	189,615	1,200	348,872	54.4%
2025-09-09	202,517	0	489,465	41.4%
2025-09-08	190,429	13	673,706	28.3%
2025-09-05	220,381	0	414,071	53.2%
2025-09-04	304,820	1,583	396,666	76.8%
2025-09-03	378,351	0	582,115	65.0%
2025-09-02	347,552	500	460,872	75.4%
2025-08-29	132,676	8,741	184,959	71.7%
2025-08-28	252,617	9,695	348,713	72.4%
2025-08-27	443,856	5,237	598,989	74.1%
2025-08-26	69,162	2,101	120,962	57.2%
2025-08-25	71,407	0	95,995	74.4%
2025-08-22	51,482	0	129,364	39.8%
2025-08-21	50,222	6,825	84,078	59.7%
2025-08-20	65,495	1,000	121,842	53.8%
2025-08-19	186,833	3,710	256,467	72.8%
2025-08-18	113,078	5,618	265,954	42.5%
2025-08-15	112,386	0	206,420	54.4%
2025-08-14	122,605	0	253,393	48.4%
2025-08-13	149,475	0	313,247	47.7%
2025-08-12	92,121	0	220,668	41.7%
2025-08-11	97,201	278	354,903	27.4%
2025-08-08	130,729	0	412,447	31.7%
2025-08-07	60,691	0	124,467	48.8%
2025-08-06	157,508	0	315,626	49.9%
2025-08-05	76,490	107	253,979	30.1%
2025-08-04	93,011	0	337,798	27.5%
2025-08-01	114,467	0	258,999	44.2%
2025-07-31	107,706	0	281,923	38.2%
2025-07-30	84,556	4,853	273,223	30.9%
2025-07-29	428,791	9,573	11,399,691	3.8%
2025-07-28	77,789	0	204,391	38.1%
2025-07-25	97,411	34	171,611	56.8%
2025-07-24	54,925	0	80,945	67.9%
2025-07-23	130,177	0	426,525	30.5%
2025-07-22	63,882	0	150,848	42.3%
2025-07-21	98,951	0	199,243	49.7%
2025-07-18	113,548	0	149,797	75.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE